Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05341726 · ClinicalTrials.gov registry record · NA

BREATHE: An Efficacy-implementation Trial Among Black Adults With Uncontrolled Asthma

A NA study of Asthma, sponsored by Columbia University.

Recruiting
Registry status
NA
Development phase
400
Enrollment target
2
Study locations

NCT05341726 is a NA study of Asthma that is actively recruiting participants, run by Columbia University. The registered enrollment target is 400 participants, below the 1,562-participant average among 374 other Asthma trials with a reported enrollment target (74% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05341726, a NA study of Asthma, is actively recruiting participants, sponsored by Columbia University.

RECRUITING
Registry status
NA
Development phase
400 participants
Enrollment target
2
Study locations

Study Summary

This study is an efficacy-implementation trial to: 1. evaluate systematically the efficacy of BREATHE in 200 Black adults receiving care at urban federally qualified health centers (FQHCs) for uncontrolled asthma; and 2. identify multi-level barriers and facilitators to the widespread adoption and implementation of BREATHE in FQHCs.

Conditions Studied

Interventions

  • BEHAVIORAL Control Intervention
  • BEHAVIORAL BREATHE Intervention

Study Locations (2)

New York

  • Sun River Health - Beacon
  • Bedford Stuyvesant Family Health Center - Brooklyn

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2023-01-19
Est. Completion 2026-07
Phase NA

Sponsor

Columbia University

958 total trials

What the Registry Record Tells You About NCT05341726

The ClinicalTrials.gov registry entry for NCT05341726 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,562-participant average among 374 other Asthma trials with a reported enrollment target (74% lower). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 2 interventions - of which Control Intervention is the first listed.

NCT05341726 reports 2 study locations spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT05341726 about?

NCT05341726 is a clinical study titled "BREATHE: An Efficacy-implementation Trial Among Black Adults With Uncontrolled Asthma". This study is an efficacy-implementation trial to: 1. evaluate systematically the efficacy of BREATHE in 200 Black adults receiving care at urban federally qualified health centers (FQHCs) for uncontrolled asthma; and 2. identify multi-level barriers and facilitators to the widespread adoption and ...

What is the current status of trial NCT05341726?

This trial is currently recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2023-01-19. Estimated completion is 2026-07.

What conditions does trial NCT05341726 study?

This clinical trial studies the following conditions: Asthma.

What interventions are being tested in trial NCT05341726?

The interventions under investigation include: Control Intervention (BEHAVIORAL), BREATHE Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT05341726?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05341726 being conducted?

This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Asthma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.